ANGLE plc

(OTCQX:ANPCY)

Latest On ANGLE plc (ANPCY):

Date/Time Type Description Signal Details
2023-04-19 07:15 ESTNewsANGLE partners with BioViewN/A
2023-04-13 15:58 ESTNewsAngle bags a pharma service contract for Crescendo BiologicsN/A
2022-10-18 14:36 ESTNewsAngle to close Canadian facilities to increase cash runwayN/A
2022-05-25 10:29 ESTNewsAngle Parsortix system gets FDA nod for harvesting cancer cells for analysisN/A
2020-12-04 06:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:53 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 12:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 12:06 ESTNewsAngle Plc reports 1H resultsN/A
2020-10-08 21:15 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:42 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:22 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 15:10 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:48 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:30 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:10 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:54 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 16:05 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:28 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 12:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:38 ESTFinancialsCompany financials have been released.Neutral
2020-07-03 07:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:42 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 07:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:09 ESTFinancialsCompany financials have been released.Neutral

About ANGLE plc (ANPCY):

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application. The company was founded in 1994 and is based in Guildford, the United Kingdom.

See Advanced Chart

General

  • Name ANGLE plc
  • Symbol ANPCY
  • Type Common Stock
  • Exchange OTCQX
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Fiscal Year EndApril
  • Web URLhttp://www.angleplc.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 175.86
  • Price/Book (Most Recent Quarter) 7.8
  • Enterprise Value Revenue 260.06
View More

Financials

  • Most Recent Quarter 2020-04-30
  • Return on Assets -24%
  • Revenue Per Share $0
  • Gross Profit -120000
  • Quarterly Earnings Growth -38.8%
View More

Highlights

  • Market Capitalization 249.29 million
View More

Share Statistics

  • Shares Outstanding 21.54 million
  • Shares Float 15.55 million
  • % Held by Insiders <1%
View More

Technicals

  • Beta 0.88
  • 52 Week High $17.46
  • 52 Week Low $4.45
  • 50 Day Moving Average 12.68
  • 200 Day Moving Average 8.85
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ANGLE plc (ANPCY) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ANGLE plc (ANPCY) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-04-302020-06-30$N/A-$0.02$0.00
2020-01-312020-03-31$N/A-$0.02$0.00
2019-04-302019-06-30$2.2 million-$0.02$0.00
2019-01-312019-04-30$2.31 million-$0.02$0.00
2018-10-312019-01-31$174262.73-$0.02$0.00
2018-01-312018-04-30$220000-$0.02$0.00
2017-10-312018-01-31$94000-$0.03$0.00
2017-07-312017-10-31$94000-$0.03$0.00
2017-04-302017-07-31$N/A-$0.03$0.00
2016-07-312016-10-31-$0.02$0.00
2016-04-302016-07-31-$0.02$0.00
2016-01-312016-04-30-$0.03$0.00
2015-10-312016-01-31-$0.03$0.00
2015-07-312015-10-31-$0.03$0.00
2015-04-302015-07-31-$0.03$0.00
2015-01-312015-04-30-$0.03$0.00
2014-10-312015-01-31-$0.03$0.00
2014-07-312014-10-31-$0.03$0.00
2014-04-302014-07-31-$0.03$0.00
2013-07-312013-10-31-$0.01$0.00
2013-04-302013-07-31-$0.01$0.00
2013-01-312013-04-30-$0.01$0.00
2012-10-312013-01-31-$0.01$0.00
2012-07-312012-10-31-$0.01$0.00
2012-04-302012-07-31-$0.01$0.00
2012-01-312012-04-30-$0.02$0.00
2011-10-312012-01-31-$0.02$0.00
2011-07-312011-10-31-$0.04$0.00
2011-04-302011-07-31-$0.04$0.00
2011-01-312011-04-30-$0.01$0.00
2010-10-312011-01-31-$0.01$0.00

ANGLE plc (ANPCY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Apr 30 2020 Jan 31 2020 Oct 31 2019 Aug 31 2019 Jul 31 2019
Research Development N/A N/A N/A N/A N/A
Income Before Tax N/A N/A -32.47 million N/A -18.51 million
Selling General Administrative N/A N/A 34.25 million N/A 19.52 million
Gross Profit N/A N/A 1.53 million N/A 870699.06
Ebit N/A N/A -32.54 million N/A -18.55 million
Operating Income N/A N/A -32.54 million N/A -18.55 million
Income Tax Expense -511000 -511000 -516500 -516500 -516500
Total Revenue N/A N/A 2.04 million N/A 1.16 million
Cost of Revenue N/A N/A 514272.38 N/A 293135.4
Total Other Income Expense Net N/A N/A 71285.27 N/A 40632.62
Net Income From Continuing Operations N/A N/A -27.21 million N/A -15.51 million
Net Income Applicable to Common Shares -2.38 million -2.38 million -2.67 million -2.67 million -2.67 million
Cash Flow:
Date Apr 30 2020 Jan 31 2020 Oct 31 2019 Aug 31 2019 Jul 31 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities 35500 35500 -642500 -642500 -642500
Total Cash Flow from Investing Activities -582500 -582500 -839500 -839500 -839500
Net Borrowings -139500 -139500 -90000 -90000 -90000
Total Cash Flow from Financial Activities N/A N/A 85.29 million N/A 48.62 million
Change to Operating Activities N/A N/A N/A N/A N/A
Change in Cash N/A N/A 47.85 million N/A 27.28 million
Total Cash from Operating Activities -1.78 million -1.78 million -2.84 million -2.84 million -2.84 million
Depreciation N/A N/A 2.97 million N/A 1.69 million
Other Cash Flow from Investing Activities 30000 30000 12000 12000 12000
Change to Inventory N/A N/A 157845.97 N/A 89972.22
Change to Account Receivables N/A N/A 1.37 million N/A 780726.91
Other Cash Flow from Financing Activities -4000 -4000 5000 5000 5000
Change to Net Income 451000 451000 -435500 -435500 -435500
Capital Expenditures N/A N/A 2.09 million N/A 1.19 million
Balance Sheet:
Date Apr 30 2020 Jan 31 2020 Oct 31 2019 Aug 31 2019 Jul 31 2019
Total Liabailities 3.74 million N/A 3.59 million N/A 20.81 million
Total Stockholder Equity 25.76 million N/A 31.15 million N/A 180.84 million
Other Current Liabilities N/A N/A N/A 31.15 million N/A
Total Assets 29.51 million N/A 34.74 million 2.99 million 201.65 million
Common Stock 17.28 million 17.28 million 17.28 million N/A 17.28 million
Other Current Assets N/A N/A N/A 17.28 million N/A
Retained Earnings -63.03 million -63.03 million -57.44 million -57.44 million -57.44 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets N/A N/A 2.99 million 2.99 million 2.99 million
Cash 13.79 million N/A 20.41 million 20.41 million 118.46 million
Total Current Liabilities 2.13 million 2.13 million 2.09 million 2.09 million 12.12 million
Other Stockholder Equity 4.23 million 4.23 million 4.05 million 4.05 million 4.05 million
Property, Plant & Equipment 3.05 million 3.05 million 3.1 million 3.1 million 3.1 million
Total Current Assets 18.01 million 18.01 million 24.87 million 24.87 million 144.38 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 17.32 million 17.32 million 27.38 million 27.38 million 27.38 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory 905000 905000 847000 847000 4.92 million
Accounts Payable 2.13 million 2.13 million 2.09 million 2.09 million 12.12 million

ANGLE plc (ANPCY) Chart:

ANGLE plc (ANPCY) News:

Below you will find a list of latest news for ANGLE plc (ANPCY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ANGLE plc (ANPCY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

ANGLE plc (ANPCY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2014-10-10F-6Registration of American Depository Receipt shares, not immediately effectivehttps://www.sec.gov/Archives/edgar/data/1620678/000101915514000371/0001019155-14-000371-index.htm
2020-04-15F-6Registration of American Depository Receipt shares, not immediately effectivehttps://www.sec.gov/Archives/edgar/data/1620678/000119380520000488/0001193805-20-000488-index.htm
2015-02-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1620678/000162067815000001/0001620678-15-000001-index.htm
2014-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1620678/999999999514003141/9999999995-14-003141-index.htm
2020-04-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1620678/999999999520000902/9999999995-20-000902-index.htm